- Cord stem cell banking is the process of collecting and storing stem cells from the umbilical cord blood or tissue, which can be used in the future for treating various medical conditions such as leukemia and blood disorders
- The cord stem cell banking market is growing rapidly due to the increasing adoption of stem cell storage services for future medical use, with more families opting to preserve umbilical cord blood after childbirth
- For instance, Cord Blood Registry has stored over 500,000 cord blood units, helping families secure potential treatment options for various diseases
- Advancements in stem cell research are significantly driving the market. Institutions such as the Harvard Stem Cell Institute have made breakthroughs in regenerative medicine, investigating how stem cells can potentially treat conditions such as Parkinson’s disease, which boosts the interest in cord blood banking
- The rise in both private and public cord blood banks is also contributing to market growth. New York Blood Center is one of the largest public cord blood banks in the world, providing cord blood for life-saving transplantations and clinical trials for diseases such as leukemia and sickle cell anemia
- Growing awareness about the benefits of cord stem cells in treating a variety of diseases, including genetic disorders and blood cancers, is encouraging more parents to store their children’s cord blood
- For instance, Cryo-Cell International reports a rise in family interest in banking due to these health benefits
- Ongoing investments in stem cell research and technology are expanding the availability of cord blood services. Companies such as LifebankUSA are leading the charge, partnering with hospitals and research institutions to make stem cells more accessible for regenerative therapies, including those for heart disease and spinal cord injuries
Frequently Asked Questions
The market is segmented based on Segmentation, By Storage Type (Private Banks, Hybrid Banks, and Public Banks), Product Type (Cord Blood, Cord Blood, and Cord Tissue), Service Type (Collection & Transportation, Processing, Analysis, and Storage), Source (Umbilical Cord Blood, Bone Marrow, Peripheral Blood Stem, and Menstrual Blood), Indication (Cerebral Palsy, Thalassemia, Leukemia, Diabetes, and Autism)- Industry Trends and Forecast to 2032.
.
The Global Cord Stem Cell Banking Market size was valued at USD 11.34 USD million in 2024.
The Global Cord Stem Cell Banking Market is projected to grow at a CAGR of 22% during the forecast period of 2025 to 2032.
The major players operating in the market include CBR SystemsInc. Cordlife , Cryo-Cell InternationalInc. ViaCord , Cryo-Save , LifeCell International Pvt. Ltd. , StemCyte India Therapeutics Pvt. Ltd , Global Cord Blood Corporation , Smart Cells International Limited , Vita 34 1997 - 2023Inc , Lisata Therapeutics, 2023 , BrainStorm Cell Limited , Regrow Biosciences Pvt. Ltd. .
The market report covers data from the North America.
